Plasma exchange therapy is effective for severe relapses in MS patients who respond inadequately to standard corticosteroids, ...

A sublingual formulation of cladribine showed comparable pharmacological properties to its name brand counterpart, Mavenclad.

I drive a wheelchair now. Mine tilts and reclines, so it’s a bit heavier than most. It’s not a car, but there’s a certain amount of responsibility that goes with it because like any vehicle, it too is ...

A sublingual formulation of cladribine, which is the active ingredient of the approved oral treatment Mavenclad, in relapsing multiple sclerosis (MS), showed comparable pharmacological properties ...

Anti-CD20 therapies like Ocrevus and rituximab may be ineffective at slowing disability progression in PPMS patients, per a ...

Cionic is partnering with a veteran-owned business to improve access to its Neural Sleeve for improving patients' walking ...

Columnist Desiree Lama's MS symptoms have almost always been invisible, which can prompt judgment and questioning from others ...

Columnist Leigh Anne Nelson followed the most current information about MS and COVID-19 and flu vaccines when deciding to get ...